There are 398 resources available
203P - Curative treatment outcomes in metaplastic breast cancer
Presenter: Ling Fung Nelson Yit
Session: Poster Display session
204TiP - A Phase II Study of HER3-DXD in Patients (pts) with Metastatic Breast Cancer (MBC)
Presenter: Erika Hamilton
Session: Poster Display session
205TiP - ATRACTIB: A Phase 2 Trial of First-Line (1L) Atezolizumab (A) in Combination with Paclitaxel (P) and Bevacizumab (B) in Metastatic Triple-Negative Breast Cancer (mTNBC)
Presenter: Antonio Llombart Cussac
Session: Poster Display session
206TiP - Randomized, Multicenter, International Phase 3 ARTEST Study to Evaluate Enobosarm Versus Active Control for the Treatment of AR+ ER+ HER2- Metastatic Breast Cancer in Patients Who Previously Received an Estrogen Blocking Agent and a CDK 4/6 inhibitor
Presenter: Adam Brufsky
Session: Poster Display session
207TiP - Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic breast cancer (HER2CLIMB-05, trial in progress)
Presenter: Veronique Dieras
Session: Poster Display session
208TiP - SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician’s choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+) / PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial
Presenter: Eva Ciruelos
Session: Poster Display session
250TiP - HER2-positive and HER2-low Breast Cancer Patients in the ACE-Pan tumor-01 study: Phase 1 Study evaluating ARX788 as Monotherapy in Advanced Solid Tumors with HER2-expression or mutation
Presenter: Janice Lu
Session: Poster Display session
209P - Clinically Relevant Impact of Persistent Peripheral Neuropathy on Health-Related Quality of Life among Early-Stage Breast Cancer Survivors: A Population-Based Study
Presenter: Kristina Engvall
Session: Poster Display session
210P - Worsening of breast cancer patients’ condition: what happened during Covid-19?, A meta-analysis.
Presenter: Mostafa Nagy
Session: Poster Display session
211P - Assessment of the financial toxicity after oncological treatment in patients with breast cancer in private oncological reference institutions in Brazil.
Presenter: Aline Vieira
Session: Poster Display session